Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
fibrillin 1 | 0.417 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 12 | |||||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
transforming growth factor beta receptor 1 | 0.451 | 0.885 | 0.85 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
presenilin 1 | 0.469 | 0.846 | 0.97 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
transcription factor AP-2 alpha | 0.488 | 0.769 | 0.99 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2015 | ||||||||
|
fibrillin 2 | 0.505 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
solute carrier family 35 member A2 | 0.525 | 0.808 | 0.72 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
RAD21 cohesin complex component | 0.528 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
lysine methyltransferase 2B | 0.529 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
heterogeneous nuclear ribonucleoprotein K | 0.539 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
sodium voltage-gated channel alpha subunit 4 | 0.554 | 0.731 | 1.3E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2004 | 2008 | ||||||||
|
bromodomain PHD finger transcription factor | 0.560 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
MAGE family member L2 | 0.560 | 0.654 | 0.98 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
myotubularin 1 | 0.573 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
selenoprotein N | 0.575 | 0.692 | 9.8E-10 |
|
disease | 0.100 | None | 0 | 3 | |||||||||||
|
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | 0.579 | 0.731 | 1.5E-15 |
|
disease | 0.100 | None | 0 | 1 |